Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy

被引：11

作者：

Ashrani, A. A.

Gabriel, D. A.

Gajewski, J. L.

Jacobs, D. R., Jr.

Weisdorf, D. J.

Key, N. S.

机构：

[1] Univ Minnesota, Dept Med, Minneapolis, MN USA

[2] Univ N Carolina, Dept Med, Chapel Hill, NC USA

[3] Univ Texas, MD Anderson Canc Ctr, Dept Med, Houston, TX 77030 USA

[4] Univ Minnesota, Dept Epidemiol, Minneapolis, MN USA

来源：

BONE MARROW TRANSPLANTATION | 2006年 / 38卷 / 12期

关键词：

D O I：

10.1038/sj.bmt.1705535

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：825 / 828

页数：4

共 9 条

[1] Off-label use of recombinant factor VIIa in patients following bone marrow transplantation [J].

Blatt, J ;

Gold, SH ;

Wiley, JM ;

Monahan, PE ;

Cooper, HC ;

Harvey, D .

BONE MARROW TRANSPLANTATION, 2001, 28 (04) :405-407

[2] INSOLUBLE FIBRIN CLOTS WITHIN URINARY-TRACT AS A CONSEQUENCE OF EPSILON AMINOCAPROIC ACID THERAPY [J].

COGGINS, JT ;

ALLEN, TD .

JOURNAL OF UROLOGY, 1972, 107 (04) :647-&

[3] Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven®) after allogenic bone marrow transplantation [J].

Karimi, M ;

Zakerinia, M ;

Khojasteh, HN ;

Ramzi, M ;

Ahmad, E .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (10) :1853-1855

[4] Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease [J].

Key, NS ;

Slungaard, A ;

Dandelet, L ;

Nelson, SC ;

Moertel, C ;

Styles, LA ;

Kuypers, FA ;

Bach, RR .

BLOOD, 1998, 91 (11) :4216-4223

[5] Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation [J].

Pihusch, M ;

Bacigalupo, A ;

Szer, J ;

Prondzinski, MV ;

Gaspar-Blaudschun, B ;

Hyveled, L ;

Brenner, B .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (09) :1935-1944

[6] The use of recombinant factor VIIa in the treatment of bleeding disorders [J].

Roberts, HR ;

Monroe, DM ;

White, GC .

BLOOD, 2004, 104 (13) :3858-3864

[7] Risk factors for severe hemorrhagic cystitis following BMT [J].

Seber, A ;

Shu, XO ;

Defor, T ;

Sencer, S ;

Ramsay, N .

BONE MARROW TRANSPLANTATION, 1999, 23 (01) :35-40

[8]

West NJ, 1997, PHARMACOTHERAPY, V17, P696

[9]

WILLIAMS JRB, 1951, BRIT J EXP PATHOL, V32, P530

← 1 →